<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_SYNBIO127 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEmmc1 docx ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Synth Syst Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Synth Syst Biotechnol</journal-id><journal-title-group><journal-title>Synthetic and Systems Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2405-805X</issn><publisher><publisher-name>KeAi Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6556621</article-id><article-id pub-id-type="publisher-id">S2405-805X(19)30019-5</article-id><article-id pub-id-type="doi">10.1016/j.synbio.2019.05.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Genomic and transcriptional changes in response to pinene tolerance and overproduction in evolved <italic>Escherichia coli</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Niu</surname><given-names>Fu-Xing</given-names></name><email>niufx3@mail.sysu.edu.cn</email></contrib><contrib contrib-type="author" id="au2"><name><surname>Huang</surname><given-names>Yuan-Bin</given-names></name><email>huangyb35@mail2.sysu.edu.cn</email></contrib><contrib contrib-type="author" id="au3"><name><surname>Ji</surname><given-names>Liang-Nian</given-names></name><email>cesjln@mail.sysu.edu.cn</email><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Liu</surname><given-names>Jian-Zhong</given-names></name><email>lssljz@mail.sysu.edu.cn</email><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1">Institute of Synthetic Biology, MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Life Sciences, Sun Yat-Sen University, Guangzhou 510275, China</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>lssljz@mail.sysu.edu.cn</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author. <email>cesjln@mail.sysu.edu.cn</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>05</day><month>6</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>9</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>05</day><month>6</month><year>2019</year></pub-date><volume>4</volume><issue>3</issue><fpage>113</fpage><lpage>119</lpage><history><date date-type="received"><day>19</day><month>3</month><year>2019</year></date><date date-type="rev-recd"><day>19</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>&#x003b1;-Pinene is an important monoterpene, which is widely used as a flavoring agent and in fragrances, pharmaceuticals and biofuels. Although an evolved strain <italic>Escherichia coli</italic> YZFP, which had higher tolerance to pinene and titer, has been successfully used to produce high levels of pinene, the pinene titer is much lower than that of hemiterpene (isoprene) and sesquiterpenes (farnesene) to date. Moreover, the overall cellular physiological and metabolic changes caused by higher tolerance to pinene and overproduction of pinene remains unclear. To reveal the mechanism of <italic>Escherichia coli</italic> YZFP with the higher tolerance to pinene and titer, a comparative genomics and transcriptional level analyses combining with CRISPR activation (CRISPRa) and interference (CRISPRi) were carried out. The results show that the tolerance to pinene and the overproduction of pinene in <italic>E. coli</italic> may be associated with: 1) the mutations of the DXP pathway genes, the <italic>rpoA</italic> and some membrane protein genes, and their upregulations of transcription levels; and 2) the mutations of some genes and their downregulation of transcriptional levels. These comparative omics analyses provided some genetic modification strategies to further improve pinene production. Overexpression of the mutated <italic>cbpA, tabA, pitA, rpoA, sufBCDS, mutS, ispH, oppF, dusB, dnaK, dxs, dxr</italic> and <italic>flgFGH</italic> genes further improved pinene production. This study also demonstrated that combining comparative omics analysis with CRISPRa and CRISPRi is an efficient technology to quickly find a new metabolic engineering strategy.</p></abstract><abstract abstract-type="author-highlights" id="abs0015"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">A genomics and transcriptional level analyses combining with CRISPRa and CRISPRi was carried out.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">The mechanism of the tolerance to pinene and overproduction of pinene was obtained.</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">Some target genes difficultly found by rational analysis were identified.</p></list-item><list-item id="u0025"><label>&#x02022;</label><p id="p0025">Combining comparative omics analysis with CRISPRa/i is an efficient technology for metabolic engineering.</p></list-item></list></p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Comparative omics analysis</kwd><kwd>CRISPRa</kwd><kwd>CRISPRi</kwd><kwd>Pinene</kwd><kwd><italic>Escherichia coli</italic></kwd><kwd>Biosynthesis</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0030">&#x003b1;-Pinene is a natural and active monoterpene, which is widely used as flavoring agents [<xref rid="bib1" ref-type="bibr">1</xref>], chemicals [<xref rid="bib2" ref-type="bibr">2</xref>] and pharmaceuticals [<xref rid="bib3" ref-type="bibr">3</xref>], especially as a good candidate for jet fuel replacement. As a result, the biotechnological production of pinene has received increasing attention. Yang et al. first engineered an <italic>E. coli</italic> to produce 5.4&#x0202f;mg/L pinene by the coexpression of a heterologous mevalonate (MEV) pathway and &#x003b1;-pinene synthase (Pt 30) from <italic>Pinus taeda</italic> [<xref rid="bib4" ref-type="bibr">4</xref>]. Then, the combinatorial expression of <italic>Abies grandis</italic> geranyl diphosphate synthase (GPPS)- pinene synthase (PS) fusion proteins further enhanced pinene production to 32&#x0202f;mg/L in <italic>E. coli</italic> [<xref rid="bib5" ref-type="bibr">5</xref>]. The directed evolution of &#x003b1;-pinene synthase (Pt1) from <italic>P. taeda</italic> resulted in &#x003b1;-pinene production to 140&#x0202f;mg/L in <italic>E. coli</italic> [<xref rid="bib6" ref-type="bibr">6</xref>]. Dunlop et al. reported that <italic>E. coli</italic> cannot grow in the presence of 0.5% [<xref rid="bib7" ref-type="bibr">7</xref>]. To avoid high toxicity of pinene on the growth of <italic>E. coli</italic> and biosynthesis of pinene, we first improved pinene tolerance to 2.0% and pinene production to 9.9&#x0202f;mg/L from 5.6&#x0202f;mg/L through adaptive laboratory evolution after atmospheric and room temperature plasma (ARTP) mutagenesis and overexpression of the efflux pump to obtain the pinene tolerant strain <italic>Escherichia coli</italic> YZFP [<xref rid="bib8" ref-type="bibr">8</xref>]. Then, we applied a combinatorial strategy of enzymatic directed evolution and modular co-culture engineering to further increase pinene production to 166.5&#x0202f;mg/L [<xref rid="bib8" ref-type="bibr">8</xref>]. In addition, <italic>Corynebacterium glutamicum</italic> has also been successfully used as host for pinene biosynthesis. Coexpression of native 1-deoxy-d-xylulose-5-phosphate synthase (Dxs), isopentenyl diphosphate isomerase (Idi), <italic>P. taeda</italic> PS and <italic>A. grandis</italic> GPPS in <italic>C. glutamicum</italic> yielded pinene of 27&#x0202f;&#x003bc;g/g cell dry weight [<xref rid="bib9" ref-type="bibr">9</xref>]. Although some progress has been made in pinene biosynthesis, the production level of pinene is much lower than that of hemiterpene (isoprene) (gram level) [<xref rid="bib8" ref-type="bibr">8</xref>,<xref rid="bib10" ref-type="bibr">10</xref>]. Thus, further work is required to increase the production of pinene.</p><p id="p0035">In this study, we combined comparative genomics and transcriptional level analysis with CRISPR activation (CRISPRa) and inference (CRISPRi) to investigate the mechanism of <italic>E. coli</italic> YZFP with higher tolerance to pinene and overproduction. Based on these results, overexpression of the mutants further improved pinene production.</p></sec><sec id="sec2"><label>2</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1</label><title>Strains, plasmids and primers</title><p id="p0040">The bacterial strains and plasmids used in this study are listed in <xref rid="tbl1" ref-type="table">Table 1</xref>. The primers used in this study are listed in <xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Strains and plasmids used in this study.</p></caption><alt-text id="alttext0030">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Name</th><th>Description</th><th>Sources</th></tr></thead><tbody><tr><td colspan="3" align="left">Strain</td></tr><tr><td align="left"><italic>E. coli</italic> DH5&#x003b1;</td><td align="left">F- <italic>endA</italic>1 <italic>glnV</italic>44 <italic>thi</italic>-1 <italic>recA</italic>1 <italic>relA</italic>1 <italic>gyrA</italic>96 <italic>deoR nupG</italic> &#x003a6;80 <italic>dlacZ</italic> &#x00394;<italic>M15</italic> &#x00394;(<italic>lacZYA-argF</italic>) U169</td><td align="left">Invitrogen</td></tr><tr><td align="left"><italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>)</td><td align="left"><italic>lacI</italic><sup>q</sup><italic>rrnB</italic><sub>T14</sub> &#x00394;<italic>lacZ</italic><sub>WJ16</sub><italic>hsdR514</italic> &#x00394;<italic>araB AD</italic><sub>AH33</sub> &#x00394;<italic>rhaBAD</italic><sub>LD78</sub>, P<sub><italic>dxs</italic></sub>::P<sub>T5</sub></td><td align="left">[<xref rid="bib11" ref-type="bibr">11</xref>]</td></tr><tr><td align="left"><italic>E. coli</italic> YZFP</td><td align="left">The adaptive laboratory evolution strain from <italic>E. coli</italic> BW25113 (P<sub>T5-dxs</sub>), P<sub><italic>acrAB</italic></sub>::P<sub>37</sub>, SS9::P<sub>37-</sub>ttgB, tolerance to 2.0% pinene and 35&#x0202f;&#x003bc;M fosmidomycin</td><td align="left">[<xref rid="bib8" ref-type="bibr">8</xref>]</td></tr></tbody></table><table frame="hsides" rules="groups"><tbody><tr><td align="left"><italic>E. coli</italic> PINE</td><td align="left">Pinene producer, chemically induced chromosomal evolution (CIChE) strain from <italic>E. coli E. coli</italic> YZFP after integration of the TIGR-mediated gene cluster of the <italic>Abies grandis</italic> GPPS<sup>Mut</sup>- <italic>Pinus taeda</italic> Pt1<sup>MUT</sup> gene cluster</td><td align="left">[<xref rid="bib8" ref-type="bibr">8</xref>]</td></tr><tr><td align="left"><italic>E. coli</italic> MEVI</td><td align="left">CIChE strain from <italic>E. coli</italic> YZFP after integration of the mevalonate pathway</td><td align="left">[<xref rid="bib8" ref-type="bibr">8</xref>]</td></tr><tr><td colspan="3" align="left">Plasmid</td></tr><tr><td align="left">pMEVIGPS</td><td align="left">pBbA5C-MTSAe-T1f-MBI(f)-T1002i-trGPPS<sub><italic>A.grandis</italic></sub>-PS<sub><italic>A.grandi</italic></sub> coding for MEV pathway enzymes to produce pinene from glucose in <italic>E. coli,</italic> p1FA <italic>ori,</italic> P<sub>lacUVF</sub> promoter, Cm<sup>r</sup></td><td align="left">[<xref rid="bib8" ref-type="bibr">8</xref>]</td></tr><tr><td align="left">pU57-RMS</td><td align="left">pUC57 harboring P<sub>tet</sub> promoter and scRNA sequences</td><td align="left">This study</td></tr><tr><td align="left">pCRISPathBrick*</td><td align="left">Expressing dcas9(K848A/K1003A/R1060A), p15A <italic>ori</italic>, Cm<sup>r</sup></td><td align="left">[<xref rid="bib12" ref-type="bibr">12</xref>,<xref rid="bib13" ref-type="bibr">13</xref>]</td></tr><tr><td align="left">pBbB2K-GFP</td><td align="left">Addgene plasmid #35345, P<sub>tet</sub> promoter, Kan<sup>r</sup>, pBBR1 <italic>ori</italic></td><td align="left">[<xref rid="bib14" ref-type="bibr">14</xref>]</td></tr><tr><td align="left">pBbB2K-GFP*</td><td align="left">pBbB2K-GFP harboring <italic>Xho</italic>I endonuclease site after tet promoter</td><td align="left">This study</td></tr><tr><td align="left">pBbB2K-dCas9*</td><td align="left">pBbB2K containing the dcas9 (K848A/K1003A/R10R0A)</td><td align="left">This study</td></tr><tr><td align="left">pUC57-MCPSoxS</td><td align="left">pUC57 harboring the fusion gene of the codon-optimized MCP and SOX with a (GGGS) linker, P<sub>tet</sub> Promoter</td><td align="left">This study</td></tr><tr><td align="left">pBbB2K-dCas9*-MCPSoxS</td><td align="left">pBbB2K-dCas9* containing the MCPSoxS sequences</td><td align="left">This study</td></tr><tr><td align="left">pTargetB</td><td align="left"><italic>E. coli</italic> sgRNA expression vector, BglBrick vector, pMB1, Spe<sup>r</sup>, scRNA</td><td align="left">[<xref rid="bib8" ref-type="bibr">8</xref>]</td></tr><tr><td align="left">pTargetA</td><td align="left"><italic>E. coli</italic> scRNA expression vector, BglBrick vector, P<sub>tet</sub> promoter, Spe<sup>r</sup>, pMB1 <italic>ori</italic></td><td align="left">This study</td></tr><tr><td align="left">pZEABP</td><td align="left">Constitute expression vector, pBR322 <italic>ori</italic>, P37 promoter, Amp<sup>r</sup></td><td align="left">[<xref rid="bib15" ref-type="bibr">15</xref>]</td></tr></tbody></table></table-wrap></p></sec><sec id="sec2.2"><label>2.2</label><title>Whole genome resequencing and data analyses</title><p id="p0045">Genomic DNA from <italic>E. coli</italic> YZFP strain was extracted using TIANamp Bacterial DNA Kit (Tiangen Biotech Co., Beijing, China) according to the manufacturer's instruction. Genomic library construction and whole-genome resequencing were performed on the Illumina HiSeq 2500 sequencing platform by GENWIZ (Shuzhou, China). The paired-end reads from <italic>E. coli</italic> YZFP were aligned to the reference genome of <italic>E. coli</italic> MG1655 using the BWA software (version 0.7.12). Potential mutations including point mutation and insertion/deletions were identified using the Samtools software (version 1.1) and GATK module (Unified Genotyper).</p></sec><sec id="sec2.3"><label>2.3</label><title>Transcriptional level analysis</title><p id="p0050">The total RNA from <italic>E. coli</italic> cells grown for 30&#x0202f;h in shake flasks was isolated using an RNA extraction kit (Dongsheng Biotech, Guangzhou, China), following the manufacturer's instructions. RNase-free gDNaseI (Dongsheng Biotech, Guangzhou, China) was treated during the isolation procedure to eliminate possible DNA contamination. Absence of DNA was verified by control PCR reactions using the RNA as a template. RNA concentration was quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific). Only the RNA samples with 260/280 ratio (an indication of protein contamination) greater than 1.8 and 260/230 ratio (an indication of reagent contamination) greater than 2.0 were used for the analysis. The first-strand cDNA was synthesized using an All-in-OneTM First-Strand cDNA Synthesis kit (GeneCopoeia, Guangzhou, China). Quantitative real-time PCR (qRT-PCR) was performed with the All-in-OneTM qPCR Mix kit (GeneCopoeia) by an iCycler iQ5 Real Time PCR system (Bio-Rad Laboratories, California, USA). The template was 100&#x0202f;ng of cDNA. The PCR conditions were as follows: 95&#x0202f;&#x000b0;C for 10&#x0202f;min, followed by 45 cycles of denaturation at 95&#x0202f;&#x000b0;C for 10&#x0202f;s, annealing at 60&#x0202f;&#x000b0;C for 20&#x0202f;s, and extension at 72&#x0202f;&#x000b0;C for 15&#x0202f;s. The primers for qRT-PCR are presented in <xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>. All qRT-PCR quantifications were performed simultaneously with PCR amplified standard and no-template (water) controls. The expression levels were analyzed by the 2<sup>-&#x025b3;&#x025b3;Ct</sup> method described by Livak and Schmittgen [<xref rid="bib16" ref-type="bibr">16</xref>] and normalized by <italic>cysG</italic> gene expression. Finally, the ratio of the transcriptional level of the evolved <italic>E. coli</italic> YZFP strain and original <italic>E. coli</italic> BW25113 (P<sub>T5-dxs</sub>) strain of &#x0003e;1.2 or&#x0202f;&#x0003c;&#x0202f;0.8 (<italic>P</italic>&#x0202f;&#x0003c;&#x0202f;0.05, Student's t-test) was considered significant differential expression. Three biological replicates for each sample were used for qRT-PCR analysis and three technical replicates were analyzed for each biological replicate.</p></sec><sec id="sec2.4"><label>2.4</label><title>CRISPRa and CRISPRi of the mutant genes</title><p id="p0055">Dong et al. developed a CRISPR-Cas system based on the actor SoxS with simultaneous activation and repression [<xref rid="bib17" ref-type="bibr">17</xref>]. We applied this CRISPR-Cas-SoxS system [<xref rid="bib17" ref-type="bibr">17</xref>] for activating and repressing target genes in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>). To enhance specificity and reduce off-target effects, <italic>dcas9*</italic> (K848A/K1003A/R1060A) was amplified from pCRISPathBrick* with primers dCas9*-F/dCas9*-R and then cloned into the <italic>Apa</italic>LI/<italic>Xho</italic>I sites of pBbB2k-GFP* to generate pBbB2k-dCas9*. P<sub>tet</sub>-MCPSoxS fragment was synthesized by GENWIZ (Shuzhou, China) and ligate into pUC57 to obtain pUC57-MCPSOX. This fragment was cut from pUC57-MCPSOX with <italic>Bam</italic>HI/<italic>Xho</italic>I, and then cloned into <italic>Bgl</italic>II/<italic>Xho</italic>I-digested pBbB2K-dCas9* to obtain pBbB2K-dCas9*-MCPSoxS (<xref rid="appsec1" ref-type="sec">Supplementary Fig. 1A</xref>).</p><p id="p0060">Scaffold RNA (scRNA) expressing vector pTargetA was derived from pTargetB [<xref rid="bib8" ref-type="bibr">8</xref>]. P<sub>tet</sub>-scRNA fragment was synthesized by GENWIZ (Shuzhou, China) and ligate into pUC57 to obtain pUC57-RMS. This fragment was cut from pUC57-RMS with <italic>Nde</italic>I/<italic>Eco</italic>RI, and then cloned into <italic>Nde</italic>I/<italic>Eco</italic>RI-digested pTargetB to obtain pTargetA.</p><p id="p0065">The pTargetA-X series used in target single-gene activation or repression with a targeting N20 sequence of gene loci of interest, was obtained by inverse PCR using primes the target N20F and N20-genes from pTargetA, then cut with <italic>Kpn</italic>I and self-ligation. For activation, the N20 sequence was designed to target at the non-template strand at the upstream of the promoter. For repression, The N20 sequence was designed to target at the 5&#x02019; end (about 100 bp downstream of ATG) of the gene on the non-template DNA strand. Because the scRNA fragment was flanked with <italic>BamHI</italic> and <italic>BglII,</italic> the scRNA expressing vector pTargetA-XY for multiple genes was constructed from pTargetA-X and pTargetA-Y by using the standard BglBrick assemble approach [<xref rid="bib14" ref-type="bibr">14</xref>].</p><p id="p0070">To investigate the effect of the activation and repression on growth, pBbB2K-dCas9*-MCPSoxS and pTargetA-X were co-transferred into <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>). A single colony was grown in 5&#x0202f;mL LB medium in a falcon tube at 37&#x0202f;&#x000b0;C overnight. The overnight cultures were inoculated into 50&#x0202f;mL of LB medium supplement with 0.5% pinene and 200&#x0202f;nM anhydrous tetracycline with a starting OD<sub>600</sub> of 0.09. The cultures were incubated at 37&#x0202f;&#x000b0;C (200&#x0202f;rpm) for 12&#x0202f;h. The strain harboring the empty vector pTargetA, <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) (pBbB2K-dCas9*-MCPSoxS, pTargetA), was set as the control.</p><p id="p0075">To investigate the effect of the activation and repression on pinene production, pBbB2K-dCas9*-MCPSoxS, pTargetA-X and pMEVIGPS were co-transferred into <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) and then analyzed the production of pinene in shake flasks. The strain harboring the empty vector pTargetA, <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) (pBbB2K-dCas9*-MCPSoxS, pTargetA, pMEVIGPS) was set as the control.</p></sec><sec id="sec2.5"><label>2.5</label><title>Pinene production in shake flasks</title><p id="p0080">A single colony was inoculated into 5&#x0202f;mL of LB medium in a falcon tube, which was cultured overnight at 37&#x0202f;&#x000b0;C and 200&#x0202f;rpm. The overnight seed culture was then inoculated into 50&#x0202f;mL of SBMSN medium with a starting OD<sub>600</sub> of 0.1. SBMSN medium (pH 7.0) containing the following (g/L): sucrose 20, peptone 12, yeast extract 24, KH<sub>2</sub>PO<sub>4</sub> 1.7, K<sub>2</sub>HPO<sub>4</sub> 211.42, MgCl<sub>2</sub>&#x000b7;6H<sub>2</sub>O 1, ammonium oxalate 1.42, and Tween-80 2&#x0202f;mL. The main cultures were then incubated at 37&#x0202f;&#x000b0;C and 200&#x0202f;rpm until an OD<sub>600</sub> of 0.8 was reached. Then, the cultures were induced with 1&#x0202f;mM IPTG and 200&#x0202f;nM anhydrous tetracycline, and overlaid with 20% dodecane to trap pinene. After induction, the cultures were incubated at 30&#x0202f;&#x000b0;C and 130&#x0202f;rpm for 72&#x0202f;h.</p></sec><sec id="sec2.6"><label>2.6</label><title>Whole-cell biocatalysis for pinene production</title><p id="p0085">Genes were amplified from <italic>E. coli</italic> YZFP genomes using the responding primers (<xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>) and cloned into pZEABP to obtain pZEA-gene series plasmids.</p><p id="p0090"><italic>E. coli</italic> PINE harboring the target plasmid pZEA-gene and <italic>E. coli</italic> MEVI harboring the pZEABP were used for whole-cell biocatalysis. They were separately inoculated into 5&#x0202f;mL of SBMSN medium in a falcon tube, which was cultured overnight at 37&#x0202f;&#x000b0;C. The overnight cultures were then inoculated into 50&#x0202f;mL SBMSN medium with a starting OD600 of 0.1. The cultures were incubated at 20&#x0202f;&#x000b0;C for 16&#x0202f;h. The <italic>E. coli</italic> PINE culture was mixed with <italic>E. coli</italic> MEVI culture at the inoculation ration of 2:1. The mixed cells were harvested by centrifugation (6000&#x000d7;<italic>g</italic> at 4&#x0202f;&#x000b0;C) and washed twice with cooled phosphate buffer (0.1&#x0202f;M, pH 7.0). Finally, the above cells were resuspended in 10&#x0202f;mL phosphate buffer (0.1&#x0202f;M, pH 7.0) containing 20&#x0202f;g/L of sucrose, 10&#x0202f;mM MgCl<sub>2</sub> and 5&#x0202f;mM MnCl<sub>2</sub> to form the cell suspension (OD<sub>600</sub>&#x0202f;=&#x0202f;30). The reaction mixture was overlaid with 20% dodecane. The catalysis was performed for 28&#x0202f;h&#x0202f;at 30&#x0202f;&#x000b0;C and 130&#x0202f;rpm.</p><p id="p0095">For inverse engineering using CRISPRi, <italic>E. coli</italic> PINE (pBbB2K-dCas9*-MCPSoxS, pTargetA-X) and <italic>E. coli</italic> MEVI (pBbB2K-GFP, pTargetA) were used for whole-cell biocatalysis as the above-mentioned process.</p></sec><sec id="sec2.7"><label>2.7</label><title>GC analysis</title><p id="p0100">Pinene concentration in the dodecane layer was assayed as previously reported [<xref rid="bib8" ref-type="bibr">8</xref>]. Take the dodecane layer and dilute it in ethylacetate spiked with the internal standard limonene. The samples were analyzed by GC-FID by using a standard curve of &#x003b1;-pinene (Sigma Aldrich). The GC-FID (Techcomp GC7900, Techcomp Ltd, China) was used with a TM-5 column (30&#x0202f;m&#x0202f;&#x000d7;&#x0202f;0.32&#x0202f;mm&#x0202f;&#x000d7;&#x0202f;0.50&#x0202f;&#x003bc;m). The inlet temperature was set to 300&#x0202f;&#x000b0;C, with a flow at 1&#x0202f;mL/min, oven at 50&#x0202f;&#x000b0;C for 30&#x0202f;s, ramp at 4&#x0202f;&#x000b0;C/min to 70&#x0202f;&#x000b0;C, and ramp at 25&#x0202f;&#x000b0;C/min to 240&#x0202f;&#x000b0;C.</p></sec><sec id="sec2.8"><label>2.8</label><title>Statistical analysis</title><p id="p0105">All experiments were conducted in triplicate, and data were averaged and presented as the means&#x0202f;&#x000b1;&#x0202f;standard deviation. Oneway analysis of variance followed by Tukey's test was used to determine significant differences using the OriginPro (version 9.0) package. Statistical significance was defined as p&#x0202f;&#x0003c;&#x0202f;0.05.</p></sec></sec><sec id="sec3"><label>3</label><title>Results and discussion</title><sec id="sec3.1"><label>3.1</label><title>Whole genome resequencing</title><p id="p0110">In our previous study [<xref rid="bib8" ref-type="bibr">8</xref>], we obtain an evolved strain <italic>E. coli</italic> YZFP, which showed a higher tolerance to pinene and titer. To investigate the relationship between the genotype and the phenotype of <italic>E. coli</italic> YZFP, the whole genome of <italic>E. coli</italic> YZFP was re-sequenced using a 2&#x02715;150 paired-end (PE) configuration. The genome sequencing generated 13548860 clean reads and achieved a mean depth of 399&#x02715; and the mapped reads ratio of 99.79% (<xref rid="tbl2" ref-type="table">Table 2</xref>). After alignment to the genome sequence of <italic>E. coli</italic> MG1655, a genome coverage of 99.36% with covered bases of 4612119 bp was obtained. A total of 349 single nucleotide variants (SNV) and 25 insertion/deletion (InDel) were identified. Of SNVs, 184 nonsynonymous mutation distributed among 175 mutated genes (<xref rid="tbl2" ref-type="table">Table 2</xref> and <xref rid="appsec1" ref-type="sec">Supplementary Table 2</xref>). These nonsynonymous mutant genes were mainly involved in the membrane protein transport processing (49 genes), the genetic information processing (32 genes), the carbohydrate metabolism (26 genes), the stress response (11 genes), the amino acid metabolism (10 genes), the cellular processes (9 genes), the human diseases (7 genes), the nucleotide metabolism (6 genes), the biosynthesis of other secondary metabolism (5 genes), the lipid metabolism (4 genes), the metabolism of cofactors and vitamins (4 genes), the metabolism of terpenoids and polyketides (4 genes), the glycan biosynthesis and metabolism (3 genes), the energy metabolism (3 genes), and the xenobiotics biodegradation and metabolism (2 genes) (<xref rid="fig1" ref-type="fig">Fig. 1</xref>).<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>The SNV and InDel mutants in <italic>E. coli</italic> YZFP<xref rid="tbl2fna" ref-type="table-fn">a</xref>.</p></caption><alt-text id="alttext0035">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Type</th><th>Amounts of mutant</th><th>Amounts of gene</th></tr></thead><tbody><tr><td align="left">Synonymous SNV</td><td align="left">93</td><td align="left">84</td></tr><tr><td align="left">Nonsynonymous SNV</td><td align="left">184</td><td align="left">175</td></tr><tr><td align="left">Stop gaining SNV</td><td align="left">11</td><td align="left">11</td></tr><tr><td align="left">Intergenic SNV</td><td align="left">2</td><td/></tr><tr><td align="left">Upstream SNV</td><td align="left">14</td><td/></tr><tr><td align="left">Downstream SNV</td><td align="left">15</td><td/></tr><tr><td align="left">Upstream and Downstream SNV</td><td align="left">29</td><td/></tr><tr><td align="left">Total</td><td align="left">349</td><td align="left">270</td></tr><tr><td align="left">InDel</td><td align="left">25</td><td/></tr></tbody></table><table-wrap-foot><fn id="tbl2fna"><label>a</label><p id="ntpara0015">Mapped reads ratio of 99.79%, covered bases of 4612119 bp, unique read ratio of 97.77%, genome coverage of 99.36%, mean depth of 399&#x02715;. The SNVs and InDels were identified with a frequency of 1.0.</p></fn></table-wrap-foot></table-wrap><fig id="fig1"><label>Fig. 1</label><caption><p>Pathway gene ontology enrichment analysis of the nonsynonymous mutant genes.</p></caption><alt-text id="alttext0015">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig></p></sec><sec id="sec3.2"><label>3.2</label><title>Comparative transcriptional level analysis of the mutant genes</title><p id="p0115">Although comparative transcriptome analysis can provide more information, it is difficult to confirm that transcriptome changes are caused by gene mutations. Thus, we only analyzed the changes in transcriptional levels of the mutant genes. To investigate whether gene mutations caused changes in transcriptional levels in <italic>E. coli</italic> YZFP, the transcriptional levels of the nonsynonymous mutant genes (174 genes) and genes observed SNV in the upstream (8 genes) were determined using qRT-PCR and were compared with those in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>). A total of 116 genes showed significantly different expression patterns. Of them, 96 genes were up-regulated and 20 genes were down-regulated in <italic>E. coli</italic> YZFP compared to <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) (<xref rid="fig2" ref-type="fig">Fig. 2</xref>).<fig id="fig2"><label>Fig. 2</label><caption><p>The relative transcriptional levels of the nonsynonymously mutated genes in <italic>E. coli</italic> YZFP compared with those in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>). (A) Ratio was less than 1.7; (B) ratio was greater than 1.7; (C) ratio was less than 0.8. The data represent the means of three replicates, and error bars represent standard deviations.</p></caption><alt-text id="alttext0020">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec3.3"><label>3.3</label><title>Functional confirmation of the mutant genes</title><p id="p0120">Dong et al. developed a CRISPR-Cas system based on the actor SoxS with simultaneous activation and repression [<xref rid="bib17" ref-type="bibr">17</xref>]. Using this CRISPR-Cas-SoxS system enable programmable control over multiple genes with simultaneous activation and repression. Thus, we first constructed a dcas9* and SoxS expressing plasmid pBbB2K-dCas9*-MCPSoxS and scRNA expressing vector pTargetA (<xref rid="appsec1" ref-type="sec">Supplementary Fig. 1A</xref>). Then, we characterized the functions of the CRISPR-Cas-SoxS system. We constructed the scRNA plasmid for CRISPRa and CRISPRi to mCherry, respectively. When N20 sequence was designed to target the P37 promoter or the CDS of mCherry, mCherry was repressed (<xref rid="appsec1" ref-type="sec">Supplementary Fig. 1B</xref>). When N20 sequence was designed to target the upstream of the P37 promoter, mCherry was activated (<xref rid="appsec1" ref-type="sec">Supplementary Fig. 1C</xref>). These results demonstrate that the CRISPR-Cas-SoxS system can function with activation and repression.</p><p id="p0125">Thus, we applied this CRISPR-Cas-SoxS system [<xref rid="bib17" ref-type="bibr">17</xref>] for activating and repressing target genes in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) to investigate their effects on growth and pinene production. Of 96 up-regulated gens, a total of 57 up-regulated genes with higher transcription level compared to <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) was selected to be activated with CRISPRa. pBbB2K-dCas9*-MCPSoxS and pTargetA-X were co-transferred into <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>). The growth and pinene production were analyzed and compared to the control strain harboring the empty vector pTargetA. The results are presented in <xref rid="tbl3" ref-type="table">Table 3</xref> and <xref rid="appsec1" ref-type="sec">Supplementary Table 3</xref>. The activations of 23 genes resulted in increases both in tolerance to pinene and pinene production (<xref rid="tbl3" ref-type="table">Table 3</xref>). The activations of 9 genes only improved pinene production. The activations of 20 genes only enhanced the tolerance to pinene.<table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Effect of CRISPR activation of the up-regulated genes on growth and production of pinene in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>).</p></caption><alt-text id="alttext0040">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Protein</th><th>Ratio of growth<xref rid="tbl3fna" ref-type="table-fn">a</xref></th><th>Ratio of pinene concentration<xref rid="tbl3fnb" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td colspan="3" align="left"><bold>Carbohydrate metabolism</bold></td><td/></tr><tr><td align="left"><italic>ulaE</italic></td><td align="left"><sc>l</sc>-xylulose 5-phosphate 3-epimerase</td><td align="left">1.24&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.06&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td colspan="4" align="left"><bold>Metabolism of terpenoids and polyketides</bold></td></tr><tr><td align="left"><italic>ispH</italic></td><td align="left">4-hydroxy-3-methylbut-2-enyl diphosphate reductase, 4Fe-4S protein</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.19&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>dxr</italic></td><td align="left">1-deoxy-<sc>d</sc>-xylulose 5-phosphate reductoisomerase</td><td align="left">&#x02013;</td><td align="left">1.34&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>dxs</italic></td><td align="left">1-deoxyxylulose-5-phosphate synthase, thiamine triphosphate-binding, FAD-requiring</td><td align="left">&#x02013;</td><td align="left">1.39&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>ispU</italic></td><td align="left">1-deoxy-<sc>d</sc>-xylulose 5-phosphate reductoisomerase/undecaprenyl pyrophosphate synthase</td><td align="left">&#x02013;</td><td align="left">1.28&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td colspan="4" align="left"><bold>Genetic Information Processing</bold></td></tr><tr><td align="left"><italic>rpoA</italic></td><td align="left">RNA polymerase, alpha subunit</td><td align="left">1.50&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.09&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>dosP</italic></td><td align="left">oxygen sensor, c-di-GMP phosphodiesterase,</td><td align="left">1.56&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>mutS</italic></td><td align="left">methyl-directed mismatch repair protein</td><td align="left">1.10&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.29&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>cbpA</italic></td><td align="left">DnaK co-chaperone; curved DNA-binding protein/uncharacterized protein</td><td align="left">1.30&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.04&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>dusB</italic></td><td align="left">methyltransferase for 50S ribosomal subunit protein L11/tRNA-dihydrouridine synthase B</td><td align="left">1.46&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.23&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td colspan="4" align="left"><bold>Membrane protein transport Processing</bold></td></tr><tr><td align="left"><italic>gsiA</italic></td><td align="left">glutathione ABC transporter ATPase</td><td align="left">1.09&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.05&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>nlpA</italic></td><td align="left">cytoplasmic membrane lipoprotein-28</td><td align="left">1.64&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.03&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>sufBCDS</italic></td><td align="left">SufBCD Fe-S cluster assembly protein</td><td align="left">1.48&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.32&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>opgB</italic></td><td align="left">OPG periplasmic biosynthetic phosphoglycerol transferases I</td><td align="left">1.10&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.06&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>setC</italic></td><td align="left">putative arabinose efflux transporter</td><td align="left">1.14&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.10&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>oppF</italic></td><td align="left">oligopeptide ABC transporter ATPase</td><td align="left">1.14&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.13&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>ypjK</italic></td><td align="left">CP4-57 prophage; putative inner membrane protein</td><td align="left">1.16&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.10&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>btuB</italic></td><td align="left">vitamin B12/cobalamin outer membrane transporter</td><td align="left">1.05&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.11&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>pitA</italic></td><td align="left">phosphate transporter, low-affinity; tellurite importer</td><td align="left">1.15&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.17&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>cusA</italic></td><td align="left">copper/silver efflux system, membrane component</td><td align="left">1.15&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.05&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td colspan="4" align="left"><bold>Cellular Processes</bold></td></tr><tr><td align="left"><italic>yehA</italic></td><td align="left">putative fimbrial-like adhesin protein</td><td align="left">1.48&#x0202f;&#x000b1;&#x0202f;0.03</td><td align="left">1.24&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>motB</italic></td><td align="left">protein that enables flagellar motor rotation</td><td align="left">1.17&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.16&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>flgFGH</italic></td><td align="left">flagellar protein</td><td align="left">1.56&#x0202f;&#x000b1;&#x0202f;0.03</td><td align="left">1.41&#x0202f;&#x000b1;&#x0202f;0.03</td></tr><tr><td align="left"><italic>ypjA</italic></td><td align="left">adhesin-like autotransporter</td><td align="left">1.12&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>tabA</italic></td><td align="left">transcriptional repressor for divergent bdcA/biofilm modulator regulated by toxins; DUF386 family protein, cupin superfamily protein</td><td align="left">1.05&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.05&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td colspan="4" align="left"><bold>Stress response</bold></td></tr><tr><td align="left"><italic>hslU</italic></td><td align="left">molecular chaperone and ATPase component of HslUV protease</td><td align="left">1.53&#x0202f;&#x000b1;&#x0202f;0.03</td><td align="left">1.29&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>flgFGH-sufBCDS- dusB-rpoA-yehA-hslU</italic></td><td/><td align="left">3.55&#x0202f;&#x000b1;&#x0202f;0.03</td><td align="left">1.71&#x0202f;&#x000b1;&#x0202f;0.02</td></tr></tbody></table><table-wrap-foot><fn id="tbl3fna"><label>a</label><p id="ntpara0020">The ratio of OD<sub>600</sub> with CRISPRa and without.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnb"><label>b</label><p id="ntpara0025">The ratio of pinene production with CRISPRa and without.-: means no change or negative effect.</p></fn></table-wrap-foot></table-wrap></p><p id="p0130">As shown in <xref rid="tbl3" ref-type="table">Table 3</xref>, the activations of <italic>dxr, dxs, ispH</italic> and <italic>ispU</italic> improved the production of pinene. The <italic>dxr, dxs, ispH</italic> and <italic>ispU</italic> is involved in 1-deoxy-<sc>d</sc>-xylulose-5-phosphate (DXP) pathway. These activations may increase the availability of pinene precursor isopentenyl diphosphate (IPP), enhancing the production of pinene. The activation of <italic>ispH</italic> improved the tolerance to pinene and the production of pinene (<xref rid="tbl3" ref-type="table">Table 3</xref>). The <italic>ispH</italic> gene encodes 4-hydroxy-3-methylbut-2-enyl diphosphate reductase which catalyzes the formation of IPP. Li et al. reported that the activation of <italic>ispH</italic> eliminated the accumulation of the intermediate of 1-hydroxy-2-methyl-2-(E)-butenyl-4-diphosphate of DXP pathway, improving the production of carotene [<xref rid="bib18" ref-type="bibr">18</xref>]. It was reported that the mutations of Dxs<sup>E289G/N455I/E598V</sup> and Dxr<sup>K37N/K217N</sup> resulted in a 60% increase in the production of isoprene in <italic>E. coli</italic> [<xref rid="bib19" ref-type="bibr">19</xref>]. The upregulations of the DXP pathway genes may be related to that <italic>E. coli</italic> YZFP is tolerant to fosfomycin [<xref rid="bib8" ref-type="bibr">8</xref>,<xref rid="bib20" ref-type="bibr">20</xref>]. Fosfomycin is the DXP pathway inhibitor that inhibits Dxr and methylerythritol phosphate cytidyltransferase (IspD). The Fosfomycin resistant mutants show higher levels of Dxr and IspD [<xref rid="bib21" ref-type="bibr">21</xref>].</p><p id="p0135">Activation of the <italic>rpoA</italic> gene improved the tolerance to pinene and the production of pinene (<xref rid="tbl3" ref-type="table">Table 3</xref>). <italic>rpoA</italic> encodes RNA polymerase subunit alpha. The plasmid expression of the <italic>rpoA</italic> mutant has been successfully used to improve a lot of cellular traits of <italic>E. coli</italic>, including butanol tolerance [<xref rid="bib22" ref-type="bibr">22</xref>] and the production of tyrosine [<xref rid="bib23" ref-type="bibr">23</xref>]. This group developed the global transcription machinery engineering (gTME) to allow for global perturbations of transcriptome. Plasmid expression of the mutant <italic>rpoD</italic> or <italic>rpoS</italic> enhanced ethanol tolerance, lycopene overproduction [<xref rid="bib24" ref-type="bibr">24</xref>] and the production of hyaluronic acid biosynthesis [<xref rid="bib25" ref-type="bibr">25</xref>].</p><p id="p0140">Activation of some membrane protein genes, such as <italic>gsiA, nlpA, sufBCDS, opgB, setC, oppF, ypjK, btuB, pitA and cusA,</italic> also improved the tolerance to pinene and the production of pinene (<xref rid="tbl3" ref-type="table">Table 3</xref>). These activations may be beneficial to the transport of metabolite, thereby improving tolerance and pinene synthesis. Many papers demonstrated that the membrane modified transport engineering is a powerful tool for improving tolerance and product biosynthesis [<xref rid="bib26" ref-type="bibr">26</xref>,<xref rid="bib27" ref-type="bibr">27</xref>].</p><p id="p0145">All of 20 down-regulated genes were selected to be repressed with CRISPRi. And their effects of the repressions on growth and pinene production were analyzed. The results are presented in <xref rid="tbl4" ref-type="table">Table 4</xref> and <xref rid="appsec1" ref-type="sec">Supplementary Table 4</xref>. Repressions of 6 genes led to increases both in tolerance to pinene and pinene production (<xref rid="tbl4" ref-type="table">Table 4</xref>). Repressions of 3 genes only improved the tolerance to pinene (<xref rid="appsec1" ref-type="sec">Supplementary Table 4</xref>).<table-wrap position="float" id="tbl4"><label>Table 4</label><caption><p>Effect of CRISPR interference of the down-regulated genes on growth and production of pinene in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>).</p></caption><alt-text id="alttext0045">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Protein</th><th>Ratio of growth<xref rid="tbl4fna" ref-type="table-fn">a</xref></th><th>Ratio of pinene concentration<xref rid="tbl4fnb" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td colspan="4" align="left"><bold>Lipid metabolism</bold></td></tr><tr><td align="left"><italic>ydiJ</italic></td><td align="left">putative FAD-linked oxidoreductase</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.06&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td colspan="4" align="left"><bold>Metabolism of cofactors and vitamins</bold></td></tr><tr><td align="left"><italic>yjbQ</italic></td><td align="left">thiamine phosphate synthase</td><td align="left">1.08&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.08&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td colspan="4" align="left"><bold>Genetic Information Processing</bold></td></tr><tr><td align="left"><italic>prpR</italic></td><td align="left">propionate catabolism operon regulatory protein</td><td align="left">1.06&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>marR</italic></td><td align="left">transcriptional repressor of multiple antibiotic resistance</td><td align="left">1.22&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.09&#x0202f;&#x000b1;&#x0202f;0.01</td></tr><tr><td align="left"><italic>fabR</italic></td><td align="left">transcriptional repressor of <italic>fabA</italic> and <italic>fabB</italic></td><td align="left">1.09&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td colspan="4" align="left"><bold>Cellular Processes</bold></td></tr><tr><td align="left"><italic>cedA</italic></td><td align="left">cell division modulator/catalase HPII, heme d-containing</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.01</td><td align="left">1.07&#x0202f;&#x000b1;&#x0202f;0.02</td></tr><tr><td align="left"><italic>ydiJ-yjbQ-prpR-marR-fabR-cedA</italic></td><td/><td align="left">1.26&#x0202f;&#x000b1;&#x0202f;0.02</td><td align="left">1.13&#x0202f;&#x000b1;&#x0202f;0.02</td></tr></tbody></table><table-wrap-foot><fn id="tbl4fna"><label>a</label><p id="ntpara0030">The ratio of OD<sub>600</sub> with CRISPRi and without.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl4fnb"><label>b</label><p id="ntpara0035">The ratio of pinene production with CRISPRi and without.-: means no change or negative effect.</p></fn></table-wrap-foot></table-wrap></p><p id="p0150">Because the phenotype in <italic>E. coli</italic> YZFP indeed resulted from the full mutations of these mutant genes, we tested the effect of multiple genes. However, constructing the scRNA expressing vector for simultaneous activation or repression of all genes is rather time-consuming. Because the repressions of six genes improved the tolerance and titer, we assembled the scRNA expressing vector of six genes and investigated the simultaneous effect of them. For activation, we randomly selected six genes. The simultaneous activation of the <italic>flgFGH, sufBCDS, dusB, rpoA, yehA</italic> and <italic>hslU</italic> further improved growth and pinene production than single activation (<xref rid="tbl3" ref-type="table">Table 3</xref>). After simultaneous activation of the six genes, the OD<sub>600</sub> at 12&#x0202f;h was increased to 0.451&#x0202f;&#x000b1;&#x0202f;0.013 from 0.127&#x0202f;&#x000b1;&#x0202f;0.009 without activation (<xref rid="appsec1" ref-type="sec">Suppl. Fig. 2</xref>). From the grow curve (<xref rid="appsec1" ref-type="sec">Sppl. Fig. 2</xref>), we can see that the wild-type strain without activation cannot grow in the present of 0.5% pinene. After activation with the six genes, the wild-type strain can grow slightly. And the tolerant stain <italic>E. coli</italic> YZFP can grow well in the present of 0.5% pinene.</p><p id="p0155">The same result of simultaneous repression of the <italic>ydiJ, yjbQ, prpR, marR, fabR</italic> and <italic>cedA</italic> was also observed (<xref rid="tbl4" ref-type="table">Table 4</xref>). These results further demonstrated that the phenotype of <italic>E. coli</italic> YZFP is caused by the mutant genes.</p></sec><sec id="sec3.4"><label>3.4</label><title>Omics-guided genetic modifications</title><p id="p0160">The ultimate goal of systems metabolic engineering is to further improve the production of metabolite. The above results show that the activations of 26 up-regulated mutant genes improved the tolerance to pinene and pinene production. Thus, these genes were amplified from <italic>E. coli</italic> YZFP and then individually cloned into plasmid pZEABP to obtain pZEABP-gene. These plasmids were individually introduced into <italic>E. coli</italic> PINE. These strains <italic>E. coli</italic> PINE (pZEABP-gene) were individually co-cultured with <italic>E. coli</italic> MEVI (pZEABP) with whole-cell biocatalysis.</p><p id="p0165">As shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref>A, overexpression of the mutated <italic>cbpA, tabA, pitA, rpoA, sufBCDS, mutS, ispH, oppF, dusB, dnaK, dxs, dxr</italic> and <italic>flgFGH</italic> increased the production of pinene by 7%, 9%, 9%, 10%, 10%, 10%, 11%, 12%, 15%, 17%, 26%, 28% and 31%, respectively. Except for <italic>ispH</italic>, <italic>dxs</italic> and <italic>dxr</italic>, other genes cannot be identified by general rational analysis. Some target genes difficulty found by rational analysis were identified.<fig id="fig3"><label>Fig. 3</label><caption><p>Pinene production in the modular co-culture system of the whole-cell biocatalysis. (A) Using <italic>E. coli</italic> PINE (pZEABP-gene) and <italic>E. coli</italic> MEVI (pZEABP). (B) Using <italic>E. coli</italic> PINE (pBbB2K-dCas9*-MCPSoxS, pTargetA-X) and <italic>E. coli</italic> MEVI (pBbB2K-GFP, pTargetA). The data represent the means of three replicates, and error bars represent standard deviations.</p></caption><alt-text id="alttext0025">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig></p><p id="p0170"><xref rid="tbl4" ref-type="table">Table 4</xref> shows that the repressions of 6 down-regulated mutant genes improved the tolerance to pinene and pinene production. Thus, we also assayed whether these repressions can improve the production of pinene in the modular co-culture system of the whole-cell biocatalysis. It can be seen from <xref rid="fig3" ref-type="fig">Fig. 3</xref>B that these repressions in the strain tolerant to pinene did not further improve the production of pinene.</p><p id="p0175">In this study, the plasmid system was used for gene expression. However, the plasmid expression system has the drawbacks of genetic instability and antibiotics pollution problem. How about chromosome expression? In addition, the simultaneous activation of the multiple genes improved the production of pinene in <italic>E. coli</italic> BW25113(P<sub>T5-dxs</sub>) (<xref rid="tbl3" ref-type="table">Table 3</xref>). Are there synergies effects between these genes in the modular co-culture system of the whole-cell biocatalysis? All these should be needed further to investigate.</p></sec></sec><sec id="sec4"><label>4</label><title>Conclusions</title><p id="p0180">In this study, we combined comparative genomics and transcriptional level analysis with CRISPRa and CRISPRi to investigate the regulation mechanism of <italic>E. coli</italic> YZFP with higher tolerance to pinene and pinene titer. The reasons for the increased tolerance to pinene and pinene production may be associated with: 1) the mutations of the DXP pathway genes (<italic>dxr, dxs, ispH</italic> and <italic>ispU</italic>), the <italic>rpoA</italic> and some membrane protein genes (<italic>gsiA, nlpA, sufBCDS, opgB, setC, oppF, ypjK, btuB, pitA</italic> and <italic>cusA</italic>), and their upregulation of transcription levels; and 2) the mutations of some genes (<italic>ydiJ, yjbQ, prpR, marR, fabR</italic> and <italic>cedA</italic>) and their downregulation of transcriptional levels. Overexpression of the mutated <italic>cbpA, tabA, pitA, rpoA, sufBCDS, mutS, ispH, oppF, dusB, dnaK, dxs, dxr</italic> and <italic>flgFGH</italic> genes further improved pinene production in the <italic>E. coli</italic>-<italic>E. coli</italic> modular co-culture system of whole-cell biocatalysis. This study also demonstrated that combining comparative omics analysis with CRISPRa and CRISPRi is an efficient technology to quickly find a new metabolic engineering strategy.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Gomes-Carneiro</surname><given-names>M.R.</given-names></name><name><surname>Viana</surname><given-names>M.E.S.</given-names></name><name><surname>Felzenszwalb</surname><given-names>I.</given-names></name><name><surname>Paumgartten</surname><given-names>F.J.R.</given-names></name><name><surname>Toxicology</surname><given-names>C.</given-names></name></person-group><article-title>Evaluation of &#x003b2;-myrcene, &#x003b1;-terpinene and (+)- and (&#x02212;)-&#x003b1;-pinene in the Salmonella/microsome assay</article-title><source>Food Chem Toxicol</source><volume>43</volume><issue>2</issue><year>2005</year><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">15621337</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>Z.H.</given-names></name></person-group><article-title>Study on the pinene isomerization catalyzed by TiM</article-title><source>Chin J Chem Eng</source><volume>26</volume><issue>12</issue><year>2018</year><fpage>2537</fpage><lpage>2541</lpage></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name></person-group><article-title>&#x003b1;-Pinene inhibits human prostate cancer growth in a mouse xenograft model</article-title><source>Chemotherapy</source><volume>63</volume><issue>1</issue><year>2017</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">29069647</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.M.</given-names></name><name><surname>Nie</surname><given-names>Q.J.</given-names></name><name><surname>Ren</surname><given-names>M.</given-names></name><name><surname>Feng</surname><given-names>H.R.</given-names></name><name><surname>Jiang</surname><given-names>X.L.</given-names></name><name><surname>Zheng</surname><given-names>Y.N.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>H.B.</given-names></name><name><surname>Xian</surname><given-names>M.</given-names></name></person-group><article-title>Metabolic engineering of <italic>Escherichia coli</italic> for the biosynthesis of alpha-pinene</article-title><source>Biotechnol Biofuels</source><volume>6</volume><issue>1</issue><year>2013</year><fpage>60</fpage><pub-id pub-id-type="pmid">23631625</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Sarria</surname><given-names>S.</given-names></name><name><surname>Wong</surname><given-names>B.</given-names></name><name><surname>Garcia Martin</surname><given-names>H.</given-names></name><name><surname>Keasling</surname><given-names>J.D.</given-names></name><name><surname>Peralta-Yahya</surname><given-names>P.</given-names></name></person-group><article-title>Microbial synthesis of pinene</article-title><source>ACS Synth Biol</source><volume>3</volume><issue>7</issue><year>2014</year><fpage>466</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">24679043</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Tashiro</surname><given-names>M.</given-names></name><name><surname>Kiyota</surname><given-names>H.</given-names></name><name><surname>Kawai-Noma</surname><given-names>S.</given-names></name><name><surname>Saito</surname><given-names>K.</given-names></name><name><surname>Ikeuchi</surname><given-names>M.</given-names></name><name><surname>Iijima</surname><given-names>Y.</given-names></name><name><surname>Umeno</surname><given-names>D.</given-names></name></person-group><article-title>Bacterial production of pinene by a laboratory-evolved pinene-synthase</article-title><source>ACS Synth Biol</source><volume>5</volume><issue>9</issue><year>2016</year><fpage>1011</fpage><lpage>1020</lpage><pub-id pub-id-type="pmid">27247193</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>M.J.</given-names></name><name><surname>Dossani</surname><given-names>Z.Y.</given-names></name><name><surname>Szmidt</surname><given-names>H.L.</given-names></name><name><surname>Chu</surname><given-names>H.C.</given-names></name><name><surname>Lee</surname><given-names>T.S.</given-names></name><name><surname>Keasling</surname><given-names>J.D.</given-names></name><name><surname>Hadi</surname><given-names>M.Z.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>A.</given-names></name></person-group><article-title>Engineering microbial biofuel tolerance and export using efflux pumps</article-title><source>Mol Syst Biol</source><volume>7</volume><issue>1</issue><year>2014</year><fpage>487</fpage></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>F.X.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y.Q.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name></person-group><article-title>Enhancing production of pinene in <italic>Escherichia coli</italic> by using a combination of tolerance, evolution and modular co-culture engineering</article-title><source>Front Microbiol</source><volume>9</volume><year>2018</year><fpage>1623</fpage><pub-id pub-id-type="pmid">30108554</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>M.K.</given-names></name><name><surname>Eom</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Um</surname><given-names>Y.</given-names></name><name><surname>Woo</surname><given-names>H.M.</given-names></name></person-group><article-title>Biosynthesis of pinene from glucose using metabolically-engineered <italic>Corynebacterium glutamicum</italic></article-title><source>Biotechnol Lett</source><volume>36</volume><issue>10</issue><year>2014</year><fpage>2069</fpage><lpage>2077</lpage><pub-id pub-id-type="pmid">24930112</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>F.X.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Bu</surname><given-names>Y.F.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name></person-group><article-title>Metabolic engineering for the microbial production of isoprenoids: carotenoids and isoprenoid-based biofuels</article-title><source>Synth Syst Biotechnol</source><volume>2</volume><issue>3</issue><year>2017</year><fpage>167</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">29318197</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y.Y.</given-names></name><name><surname>Ling</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.Y.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name></person-group><article-title>Production of shikimic acid from <italic>Escherichia coli</italic> through chemically inducible chromosomal evolution and cofactor metabolic engineering</article-title><source>Microb Cell Factories</source><volume>13</volume><issue>1</issue><year>2014</year><fpage>21</fpage></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name></person-group><article-title>Transcriptomic changes in response to putrescine production in metabolically engineered <italic>Corynebacterium glutamicum</italic></article-title><source>Front Microbiol</source><volume>8</volume><year>2017</year><fpage>1987</fpage><pub-id pub-id-type="pmid">29089930</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Shen</surname><given-names>Y.P.</given-names></name><name><surname>Jiang</surname><given-names>X.L.</given-names></name><name><surname>Feng</surname><given-names>L.S.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name></person-group><article-title>Metabolic evolution and a comparative omics analysis of <italic>Corynebacterium glutamicum</italic> for putrescine production</article-title><source>J Ind Microbiol Biotechnol</source><volume>45</volume><issue>2</issue><year>2018</year><fpage>123</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">29344811</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>T.S.</given-names></name><name><surname>Krupa</surname><given-names>R.A.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Hajimorad</surname><given-names>M.</given-names></name><name><surname>Holtz</surname><given-names>W.J.</given-names></name><name><surname>Prasad</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Keasling</surname><given-names>J.D.</given-names></name></person-group><article-title>BglBrick vectors and datasheets: a synthetic biology platform for gene expression</article-title><source>J Biol Eng</source><volume>5</volume><issue>1</issue><year>2011</year><fpage>12</fpage><pub-id pub-id-type="pmid">21933410</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.R.</given-names></name><name><surname>Tian</surname><given-names>G.Q.</given-names></name><name><surname>Shen</surname><given-names>H.J.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name></person-group><article-title>Metabolic engineering of <italic>Escherichia coli</italic> to produce zeaxanthin</article-title><source>J Ind Microbiol Biotechnol</source><volume>42</volume><issue>4</issue><year>2015</year><fpage>627</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">25533633</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>K.J.</given-names></name><name><surname>Schmittgen</surname><given-names>T.D.</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method</article-title><source>Methods</source><volume>25</volume><issue>4</issue><year>2001</year><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>C.</given-names></name><name><surname>Fontana</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Carothers</surname><given-names>J.M.</given-names></name><name><surname>Zalatan</surname><given-names>J.G.</given-names></name></person-group><article-title>Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria</article-title><source>Nat Commun</source><volume>9</volume><issue>1</issue><year>2018</year><fpage>2489</fpage><pub-id pub-id-type="pmid">29950558</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.F.</given-names></name><name><surname>Lin</surname><given-names>Z.Q.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Z.W.</given-names></name><name><surname>Tang</surname><given-names>Y.J.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>X.M.</given-names></name></person-group><article-title>Metabolic engineering of <italic>Escherichia coli</italic> using CRISPR-Cas9 meditated genome editing</article-title><source>Metab Eng</source><volume>31</volume><year>2015</year><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">26141150</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Ye</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name></person-group><article-title>Combinatorial pathway optimization in <italic>Escherichia coli</italic> by directed co-evolution of rate-limiting enzymes and modular pathway engineering</article-title><source>Biotechnol Bioeng</source><volume>113</volume><issue>12</issue><year>2016</year><fpage>2661</fpage><lpage>2669</lpage><pub-id pub-id-type="pmid">27316379</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>A.</given-names></name><name><surname>Meadows</surname><given-names>C.W.</given-names></name><name><surname>Canu</surname><given-names>N.</given-names></name><name><surname>Keasling</surname><given-names>J.D.</given-names></name><name><surname>Lee</surname><given-names>T.S.</given-names></name></person-group><article-title>High-throughput enzyme screening platform for the IPP-bypass mevalonate pathway for isopentenol production</article-title><source>Metab Eng</source><volume>41</volume><year>2017</year><fpage>125</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">28389395</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.C.</given-names></name><name><surname>Watts</surname><given-names>K.M.</given-names></name><name><surname>Hodge</surname><given-names>D.</given-names></name><name><surname>Kemp</surname><given-names>L.M.</given-names></name><name><surname>Hunstad</surname><given-names>D.A.</given-names></name><name><surname>Hicks</surname><given-names>L.M.</given-names></name><name><surname>Odoms</surname><given-names>A.R.</given-names></name></person-group><article-title>A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling</article-title><source>Biochemistry-US</source><volume>50</volume><issue>17</issue><year>2011</year><fpage>3570</fpage><lpage>3577</lpage></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>K.M.</given-names></name><name><surname>Santos</surname><given-names>C.N.S.</given-names></name><name><surname>Yu</surname><given-names>H.M.</given-names></name><name><surname>Gregory</surname><given-names>S.</given-names></name></person-group><article-title>Mutagenesis of the bacterial RNA polymerase alpha subunit for improvement of complex phenotypes</article-title><source>Appl Environ Microbiol</source><volume>75</volume><issue>9</issue><year>2009</year><fpage>2705</fpage><lpage>2711</lpage><pub-id pub-id-type="pmid">19251886</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>C.N.S.</given-names></name><name><surname>Xiao</surname><given-names>W.H.</given-names></name><name><surname>Gregory</surname><given-names>S.</given-names></name></person-group><article-title>Rational, combinatorial, and genomic approaches for engineering L-tyrosine production in <italic>Escherichia coli</italic></article-title><source>Proc Natl Acad Sci U S A</source><volume>109</volume><issue>34</issue><year>2012</year><fpage>13538</fpage><lpage>13543</lpage><pub-id pub-id-type="pmid">22869698</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Alper</surname><given-names>H.</given-names></name><name><surname>Stephanopoulos</surname><given-names>G.</given-names></name></person-group><article-title>Global transcription machinery engineering: a new approach for improving cellular phenotype</article-title><source>Metab Eng</source><volume>9</volume><issue>3</issue><year>2007</year><fpage>258</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">17292651</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Tyo</surname><given-names>K.</given-names></name><name><surname>Alper</surname><given-names>H.</given-names></name><name><surname>Klein-Marcuschamer</surname><given-names>D.</given-names></name><name><surname>Stephanopoulos</surname><given-names>G.</given-names></name></person-group><article-title>A high-throughput screen for hyaluronic acid accumulation in recombinant <italic>Escherichia coli</italic> transformed by libraries of engineered sigma factors</article-title><source>Biotechnol Bioeng</source><volume>101</volume><issue>4</issue><year>2010</year><fpage>788</fpage><lpage>796</lpage></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>M.J.</given-names></name></person-group><article-title>Engineering microbes for tolerance to next-generation biofuels</article-title><source>Biotechnol Biofuels</source><volume>4</volume><issue>1</issue><year>2011</year><comment>32-32</comment></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Y.L.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.L.</given-names></name><name><surname>Li</surname><given-names>L.M.</given-names></name></person-group><article-title>Engineering microbial membranes to increase stress tolerance of industrial strains</article-title><source>Metab Eng</source><volume>53</volume><year>2019</year><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">30605774</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0190">The following is the Supplementary data to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>Multimedia component 1</title></caption><media xlink:href="mmc1.docx"><alt-text>Multimedia component 1</alt-text></media></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgment</title><p>We are grateful to the <funding-source id="gs1">National Natural Science Foundation of China</funding-source> (Grant NO. 201808248), the <funding-source id="gs2">Natural Science Foundation of Guangdong Province</funding-source> (NO. 2018A030310255) and the <funding-source id="gs3">Project of the Scientific and Technical Program of Guangzhou</funding-source> (No. 201607010028) for their financial support.</p></ack><fn-group><fn id="d31e992"><p id="ntpara0010">Peer review under responsibility of KeAi Communications Co., Ltd.</p></fn><fn id="appsec2" fn-type="supplementary-material"><label>Appendix A</label><p id="p0195">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.synbio.2019.05.001" id="intref0010">https://doi.org/10.1016/j.synbio.2019.05.001</ext-link>.</p></fn></fn-group></back></article>